Gene therapy improves condition of patients with muscular dystrophy

05/24/2010 | HealthDay News

U.S. scientists said three patients with limb-girdle muscular dystrophy, which is caused by a deficiency in a muscle protein called alpha-sarcoglycan, showed an increase in muscle-fiber levels and protein expression for six months after being injected with a normal gene enclosed in a virus. They said the findings might lead to treatment for patients with the disease and other types of muscular dystrophy.

View Full Article in:

HealthDay News

Published in Brief: